Exclusive: 4 Life Science Companies Merge into Discovery Life SciencesAllbiopro2018-10-17T08:46:27+09:0010월 17th, 2018|
Amid Controversy in Drug Pricing on TV Ads, Biopharma Industry Argues Free SpeechAllbiopro2018-10-17T08:46:03+09:0010월 17th, 2018|
Listen up! Researchers Find Key to Regrowing Cells Related to Hearing LossAllbiopro2018-10-17T08:45:36+09:0010월 17th, 2018|
Taiho Pharmaceutical’s Venture Arm Increases Investment Pool to $300 MillionAllbiopro2018-10-17T08:45:11+09:0010월 17th, 2018|
Dissimilar to U.S. Market, Humira Biosimilar Competition Launches in EuropeAllbiopro2018-10-17T08:44:46+09:0010월 17th, 2018|
Five-Year Data Shows Novartis’ Cosentyx Safe and Effective in Treating ArthritisAllbiopro2018-10-17T08:44:21+09:0010월 17th, 2018|
Amgen, Novartis and Banner Alzheimer’s Institute Team on 2 Alzheimer’s Prevention TrialsAllbiopro2018-10-17T08:43:56+09:0010월 17th, 2018|
Reality Check! How to Handle an Overly Optimistic Co-WorkerAllbiopro2018-10-17T08:43:31+09:0010월 17th, 2018|
Sanofi, Regeneron score positive Dupixent data in sinusitis as they await key FDA asthma verdictAllbiopro2018-10-17T08:42:39+09:0010월 17th, 2018|
EU expands look at Zhejiang Huahai as impurities show up in other ‘sartans’Allbiopro2018-10-17T08:42:13+09:0010월 17th, 2018|
China slaps monstrous $1.3B penalty on vaccine scandal culprit ChangshengAllbiopro2018-10-17T08:41:48+09:0010월 17th, 2018|
In worrying trend, vaccination rates in U.S. children keep dropping: CDC reportsAllbiopro2018-10-17T08:41:23+09:0010월 17th, 2018|
Azar deals woe to DTC—and a slap to Big Pharma—with vow to force prices into drug adsAllbiopro2018-10-17T08:40:57+09:0010월 17th, 2018|
ICER weighs plan to offer trial design advice to pharma companies, for a priceAllbiopro2018-10-17T08:40:32+09:0010월 17th, 2018|
In conversation with Tony Johnson, CEO of Goldfinch BioAllbiopro2018-10-17T08:40:06+09:0010월 17th, 2018|
Revolution Medicines to absorb Warp Drive Bio into its oncology and ‘undruggable’ discovery effortsAllbiopro2018-10-17T08:39:43+09:0010월 17th, 2018|
Novartis’ Kymriah partner doubling capacity on global viral vector demandAllbiopro2018-10-17T08:39:16+09:0010월 17th, 2018|
